News

Intraocular inflammation more common with aflibercept injections in real-world setting
The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of ...
San Francisco Examiner20d
How to Choose the Right Kratom Capsule Dosage for Your Needs
However, choosing the appropriate dosage can significantly impact your experience. Finding the perfect dose requires considering various personal factors and understanding kratom's effects clearly.
BioSpace21d
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
at different injection sites. In adults with CSU who remain symptomatic despite H1 antihistamine treatment, Dupixent 300 mg is administered every two weeks after an initial loading dose. In patients ...
Morningstar24d
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
at different injection sites. In adults with CSU who remain symptomatic despite H1 antihistamine treatment, Dupixent 300 mg is administered every two weeks after an initial loading dose.
The Globe and Mail24d
Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application
EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...